The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...
A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.
The co-founder of biotech firm Regeneron Pharmaceuticals (NASDAQ:REGN) said in a newspaper interview that popular weight-loss ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The State Health Plan's decision to end coverage of certain weight-loss prescription drugs has produced an unlikely and ...